Correlation Between Spyre Therapeutics and Gap,
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Gap, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Gap, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and The Gap,, you can compare the effects of market volatilities on Spyre Therapeutics and Gap, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Gap,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Gap,.
Diversification Opportunities for Spyre Therapeutics and Gap,
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Spyre and Gap, is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and The Gap, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gap, and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Gap,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gap, has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Gap, go up and down completely randomly.
Pair Corralation between Spyre Therapeutics and Gap,
Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 1.4 times more return on investment than Gap,. However, Spyre Therapeutics is 1.4 times more volatile than The Gap,. It trades about 0.05 of its potential returns per unit of risk. The Gap, is currently generating about 0.03 per unit of risk. If you would invest 1,640 in Spyre Therapeutics on September 14, 2024 and sell it today you would earn a total of 721.00 from holding Spyre Therapeutics or generate 43.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spyre Therapeutics vs. The Gap,
Performance |
| Timeline |
| Spyre Therapeutics |
| Gap, |
Spyre Therapeutics and Gap, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spyre Therapeutics and Gap,
The main advantage of trading using opposite Spyre Therapeutics and Gap, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Gap, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gap, will offset losses from the drop in Gap,'s long position.| Spyre Therapeutics vs. Puma Biotechnology | Spyre Therapeutics vs. Iovance Biotherapeutics | Spyre Therapeutics vs. Day One Biopharmaceuticals | Spyre Therapeutics vs. Inozyme Pharma |
| Gap, vs. Mesa Air Group | Gap, vs. Southwest Airlines | Gap, vs. Brenmiller Energy Ltd | Gap, vs. Delta Air Lines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |